478 results on '"Philis-Tsimikas, Athena"'
Search Results
52. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
53. Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the CONCLUDE trial
54. The Effect of Discontinuing Continuous Glucose Monitoring in Adults with Type 2 Diabetes Treated with Basal Insulin
55. Insulin Degludec Once-Daily in Type 2 Diabetes: Simple or Step-Wise Titration (BEGIN: Once Simple Use)
56. 100 years on: the impact of the discovery of insulin on clinical outcomes
57. 606-P: Higher Derived Time-in-Range with IDegLira vs. Insulin Glargine U100 in Patients with T2D
58. 1275-PUB: Call to Action: COVID-19 Pandemic Prompts Subcutaneous Treatment Option for Diabetes Ketoacidosis (DKA) in Hospital
59. Community-created programs: can they be the basis of innovative transformations in our health care practice? implications from 15 years of testing, translating, and implementing community-based, culturally tailored diabetes management programs
60. Teen Peer Educators and Diabetes Knowledge of Low-Income Fifth Grade Students
61. Indicadores clinicos y apoyo para el manejo de la enfermedad, la depresion, el autocuidado en hispanos que padecen diabetes tipo 2 en el Condado de San Diego, Estados Unidos
62. A New Option for Glycemic Control: Insulin Degludec, a New-Generation Basal Insulin with an Ultralong Duration of Action
63. Similar hypoglycemia duration with once-weekly icodec versus degludec or glargine U100 in insulin-treated T2D: a post hoc CGM analysis from ONWARDS 2 & 4.
64. The relationship between HbA1c and hypoglycaemia in patients with diabetes treated with insulin degludec versus insulin glargine 100 units/mL
65. Medical assistant health coaching (“MAC”) for type 2 diabetes in diverse primary care settings: A pragmatic, cluster-randomized controlled trial protocol
66. Care Team Integration in Primary Care Improves One-Year Clinical and Financial Outcomes in Diabetes: A Case for Value-Based Care
67. Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)
68. Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes.
69. Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly Controlled Type 2 Diabetes
70. Peer-Led Diabetes Education Programs in High-Risk Mexican Americans Improve Glycemic Control Compared With Standard Approaches: A Project Dulce promotora randomized trial
71. Glycemic Control Among Latinos With Type 2 Diabetes: The Role of Social-Environmental Support Resources
72. Type 2 Diabetes Care and Insulin Intensification: Is a More Multidisciplinary Approach Needed? Results From the MODIFY Survey
73. Glucose as the 5th Vital Sign: A Randomized Controlled Trial of Continuous Glucose Monitoring in a non-ICU Hospital Setting
74. Glucose as the Fifth Vital Sign: A Randomized Controlled Trial of Continuous Glucose Monitoring in a Non-ICU Hospital Setting
75. 2180-PUB: Integration of Continuous Glucose Monitoring in Diabetes Self-Management Education for Type 2 Diabetes Improves Glycemic Control
76. 646-P: Dulce Digital-Me: An Adaptive M-Health Intervention for Underserved Hispanics with Diabetes
77. 97-LB: Safety and Glycemic Outcomes of the MiniMed Advanced Hybrid Closed-Loop (AHCL) System in Subjects with T1D
78. 202-OR: Basal Insulin Digital Titration App vs. Enhanced Paper Titration Tool: A Randomized Control Study
79. 1021-P: HbA1c Levels and Rates of Hypoglycemia with Insulin Degludec U200 and Insulin Glargine U300 Stratified by Renal Function Subgroups: Post Hoc Analysis from the CONCLUDE Trial
80. 644-P: Social Media Campaign Raises Awareness of Diabetes Risks and Programs in Hispanic Communities
81. 2175-PUB: Feasibility and Preliminary Effectiveness of Continuous Glucose Monitoring for Diabetes Prevention
82. 960-P: Characteristics of U.S. Patients with Type 2 Diabetes Prescribed GLP-1RA+SGLT2i in Combination during 2018
83. Does Diabetes Distress Influence Clinical Response to an mHealth Diabetes Self-Management Education and Support Intervention?
84. Benefits of insulin degludec/liraglutide are maintained even in patients discontinuing sulphonylureas or dipeptidyl peptidase‐4 inhibitors upon initiation of degludec/liraglutide therapy: A post hoc analysis of the DUAL II and DUAL IX trials
85. The relationship between HbA1c and hypoglycaemia in patients with diabetes treated with insulin degludec versus insulin glargine 100 units/mL
86. Are Patientsʼ Initial Experiences at the Diagnosis of Type 2 Diabetes Associated With Attitudes and Selfmanagement Over Time?
87. Outcomes From a Culturally Tailored Diabetes Prevention Program in Hispanic Families From a Low-Income School Horton Hawks Stay Healthy (HHSH)
88. Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the CONCLUDE trial.
89. Process evaluation of a medical assistant health coaching intervention for type 2 diabetes in diverse primary care settings.
90. The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin.
91. Improving Treatment of Depression Among Latinos With Diabetes Using Project Dulce and IMPACT
92. Cost-Effectiveness of Diabetes Case Management for Low-Income Populations
93. PREVALENCE OF SLEEP APNEA IN A POPULATION OF ADULTS WITH TYPE 2 DIABETES MELLITUS
94. Improvement in Diabetes Care of Underinsured Patients Enrolled in Project Dulce: A community-based, culturally appropriate, nurse case management and peer education diabetes care model
95. Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.
96. Innovative Solutions to Care for Individuals With Diabetes in Underserved Populations
97. Innovative Diabetes Interventions in the U.S. Hispanic Population
98. 92 - Efficacy of Semaglutide by Background Sodium-Glucose Cotransporter-2 Inhibitor: A Posthoc Analysis of SUSTAIN 9
99. 884-P: Mi Puente: A Care Transitions Intervention for At-Risk Hispanics with Multiple Cardiometabolic Conditions
100. 2387-PUB: Effect of Pre-op Carb-Loaded Beverage in Bariatric Surgery Patients with Pre-DM and DM as Part of ERAS Protocol
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.